Integrating Deep Learning with Genomic Data for Novel Biomarker Discovery in Oncology

The explosion of genomic data presents an unprecedented opportunity for the application of machine learning techniques in computational biology, particularly in oncology. The objective of this study was to develop a robust deep learning framework capable of identifying novel biomarkers for cancer prognosis. Utilizing a dataset comprised of over 10,000 patient genomic profiles from The Cancer Genome Atlas, we implemented a convolutional neural network (CNN) model tailored for high-dimensional data. The model demonstrated an accuracy of 92% in distinguishing cancerous from non-cancerous samples, outperforming traditional logistic regression models by 15%. Key findings also included the identification of 12 potential novel biomarkers with a false discovery rate below 5%. This study highlights the transformative potential of integrating machine learning with genomic data in cancer research. Our findings suggest that deep learning approaches can significantly enhance the precision of biomarker discovery, paving the way for personalized medicine. Future work will focus on validating these biomarkers in clinical trials and expanding the model to include multi-omics data.